About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Bladder Cancer Risk Decreases With Selenium

by Rathi Manohar on September 1, 2010 at 7:03 PM
 Bladder Cancer Risk Decreases With Selenium

Increasing selenium intake may decrease the risk of bladder cancer, according to a new study.

Selenium is an essential micronutrient that is incorporated into about 25 proteins, called selenoproteins.

Advertisement

Most of these selenoproteins are enzymes with antioxidant properties that prevent cellular damage caused by the by-products of oxygen metabolism, according to lead researcher Nuria Malats, leader of the Genetic and Molecular Epidemiology Group, Human Cancer Genetics Program, Spanish National Cancer Research Center.

The main dietary sources of this micronutrient are plant foods grown in selenium-rich soils, animals who graze on these soils and selenium-enriched products.
Advertisement

"The lower the levels of selenium, the higher the risk of developing bladder cancer," Malats said.

Using data from seven previously published studies, Malats and colleagues conducted a meta-analysis to evaluate selenium levels measured in serum and toenails and the risk of developing bladder cancer.

The data included individuals mostly from the United States, but also from Belgium, Finland and the Netherlands.

The researchers noted a significant protective effect of selenium, mainly among women, which they believe may result from gender-specific differences in the mineral's accumulation and excretion in women.

"Although our results suggest a beneficial effect of high selenium intake for bladder cancer risk, more studies are needed to confirm these findings before an enforcement of high selenium intake is recommended," Malats said.

The results of the study are published in the September issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer.

Source: ANI
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Cancer News

Oral Lipid Nanoparticle Drug Averts Colitis-Associated Cancer Development
Lipid nanoparticles use M13, a potent anti-ulcerative colitis compound, in an oral formulation to combat colitis-linked cancer.
Breast Reconstruction and Shorter Radiation: The Winning Combo!
Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.
Innovative Cancer Implant Technology Holds Promise to Cut Death Rates by Half
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
Personalized Vaccine and T Cell Therapy for Ovarian Cancer Patients
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Kinase-Targeted Therapy Revolutionizes Colorectal Cancer Care
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Bladder Cancer Risk Decreases With Selenium Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests